Chemotherapy and Herceptin for HER-2+ metastatic breast cancer: The best drug?

Robert B. Livingston; Francisco J. Esteva

doi:10.1634/theoncologist.6-4-315

Chemotherapy and Herceptin for HER-2⁺ metastatic breast cancer: The best drug?

Robert B. Livingston
, Francisco J. Esteva

Cancer Center Division

Research output: Contribution to journal › Comment/debate › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	315-316
Number of pages	2
Journal	Oncologist
Volume	6
Issue number	4
DOIs	https://doi.org/10.1634/theoncologist.6-4-315
State	Published - 2001

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1634/theoncologist.6-4-315

Cite this

@article{5c92c837cdd141e7ab785132b313eabd,

title = "Chemotherapy and Herceptin for HER-2+ metastatic breast cancer: The best drug?",

author = "Livingston, \{Robert B.\} and Esteva, \{Francisco J.\}",

year = "2001",

doi = "10.1634/theoncologist.6-4-315",

language = "English (US)",

volume = "6",

pages = "315--316",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Chemotherapy and Herceptin for HER-2+ metastatic breast cancer

T2 - The best drug?

AU - Livingston, Robert B.

AU - Esteva, Francisco J.

PY - 2001

Y1 - 2001

UR - https://www.scopus.com/pages/publications/0034741923

UR - https://www.scopus.com/pages/publications/0034741923#tab=citedBy

U2 - 10.1634/theoncologist.6-4-315

DO - 10.1634/theoncologist.6-4-315

M3 - Comment/debate

C2 - 11524548

AN - SCOPUS:0034741923

SN - 1083-7159

VL - 6

SP - 315

EP - 316

JO - Oncologist

JF - Oncologist

IS - 4

ER -

Chemotherapy and Herceptin for HER-2+ metastatic breast cancer: The best drug?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Chemotherapy and Herceptin for HER-2⁺ metastatic breast cancer: The best drug?